Cargando…

Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study

Aberrant metabolisms have been hypothesized to precede the occurrence of hepatocellular carcinoma (HCC), therefore, we investigated biomarkers associated with subsequent HCC in peripheral bloods using metabolomic technologies. A cohort of 475 HCC-naïve liver cirrhotic patients were recruited and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Kung-Hao, Cheng, Mei-Ling, Lo, Chi-Jen, Lin, Yang-Hsiang, Lai, Ming-Wei, Lin, Wey-Ran, Yeh, Chau-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331577/ https://www.ncbi.nlm.nih.gov/pubmed/32616821 http://dx.doi.org/10.1038/s41598-020-67971-x

Ejemplares similares

Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Impact of an MT-RNR1 Gene Polymorphism on Hepatocellular Carcinoma Progression and Clinical Characteristics
por: Lin, Yang-Hsiang, et al.
Publicado: (2021)

Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth
por: LIN, WEY-RAN, et al.
Publicado: (2012)

Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
por: Lai, Ming-Wei, et al.
Publicado: (2022)

GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
por: Lin, Wey-Ran, et al.
Publicado: (2020)

Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody
por: Lai, Ming-Wei, et al.
Publicado: (2016)

Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia
por: Kung, Hsiu-Ni, et al.
Publicado: (2011)

Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation
por: Le, Puo-Hsien, et al.
Publicado: (2019)

Effects of Intraduodenal Infusions of L-phenylalanine and L-glutamine on Antropyloroduodenal Motility and Plasma Cholecystokinin in Healthy Men
por: Steinert, Robert E, et al.
Publicado: (2015)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Functional Role of Mitochondrial DNA in Cancer Progression
por: Lin, Yang-Hsiang, et al.
Publicado: (2022)

Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression
por: Lau, Hon-Kit, et al.
Publicado: (2016)

Glutamine and glutamate supplementation raise milk glutamine concentrations in lactating gilts
por: Manso, Helena Emilia CCC, et al.
Publicado: (2012)

GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma
por: Tsou, Yung-Kuan, et al.
Publicado: (2017)

Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma
por: Chiang, Chun-Cheng, et al.
Publicado: (2023)

Plasma Glutamine Concentrations in Liver Failure
por: Helling, Gunnel, et al.
Publicado: (2016)

Thyroid Hormone in Hepatocellular Carcinoma: Cancer Risk, Growth Regulation, and Anticancer Drug Resistance
por: Lin, Yang-Hsiang, et al.
Publicado: (2020)

Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Glutamine energy substrate anaplerosis increases bone density in the Pah(enu2) classical PKU mouse in the absence of phenylalanine restriction
por: Dobrowolski, Steven F., et al.
Publicado: (2022)

Expression of phenylalanine ammonia lyases in Synechocystis sp. PCC 6803 and subsequent improvements of sustainable production of phenylpropanoids
por: Kukil, Kateryna, et al.
Publicado: (2022)

Individual surveillance by competing risk model for patients with hepatocellular carcinoma occurrence in all-cause cirrhosis
por: Wang, Qi, et al.
Publicado: (2023)

COX5B-Mediated Bioenergetic Alterations Modulate Cell Growth and Anticancer Drug Susceptibility by Orchestrating Claudin-2 Expression in Colorectal Cancers
por: Chu, Yu-De, et al.
Publicado: (2021)

Phenylalanine Binding Is Linked to Dimerization of the Regulatory Domain of Phenylalanine Hydroxylase
por: Zhang, Shengnan, et al.
Publicado: (2014)

A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
por: Lin, Chih-Lang, et al.
Publicado: (2023)

Serum concentrations of selected adipokines in virus-related liver cirrhosis and hepatocellular carcinoma
por: Pazgan-Simon, Monika, et al.
Publicado: (2020)

SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer
por: Chu, Yu-De, et al.
Publicado: (2021)

Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008–2012
por: Yeh, Chau-Ting, et al.
Publicado: (2017)

Kinetic analysis of the role of the tyrosine 13, phenylalanine 56 and glutamine 54 network in the U1A/U1 hairpin II interaction
por: Law, Michael J., et al.
Publicado: (2005)

Acute Exacerbation of Hepatitis in Liver Cirrhosis with Very High Levels of alpha-Fetoprotein But No Occurrence of Hepatocellular Carcinoma
por: Bae, Jin Soo, et al.
Publicado: (2005)

Activation of Phenylalanine Hydroxylase by Phenylalanine Does Not Require Binding in the Active Site
por: Roberts, Kenneth M., et al.
Publicado: (2014)

Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma
por: LE, PUO-HSIEN, et al.
Publicado: (2014)

Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes—A Nationwide Cohort Study()()()
por: Chang, Yu-Tang, et al.
Publicado: (2018)

Glutamine synthetase: a tumor suppressor in hepatocellular carcinoma?
por: Dai, Weiwei, et al.
Publicado: (2023)

Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma
por: Sheu, Ming-Jen, et al.
Publicado: (2015)

Propagation of Plasma L-Phenylalanine Concentration Fluctuations to the Neurovascular Unit in Phenylketonuria: An in silico Study
por: Taslimifar, Mehdi, et al.
Publicado: (2019)

High phenylalanine concentrations induce demyelination and microglial activation in mouse cerebellar organotypic slices
por: Thau-Zuchman, Orli, et al.
Publicado: (2022)

Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases
por: Raff, Evan J., et al.
Publicado: (2015)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_viqo9jbf4atutfs3avcd19ls5g